Reported value
$20.0B
2026 Q2 filing
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| INCY | INCYTE CORP | 17.48% | 30,762,330 | ADDED (+0.1%) |
| ONC | BeOne Medicines Ltd. | 12.57% | 8,801,567 | HELD |
| RVMD | REVOLUTION MEDICINES INC | 10.74% | 11,443,357 | ADDED (+19.8%) |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 5.77% | 2,143,131 | ADDED (+0.1%) |
| ACAD | ACADIA PHARMACEUTICALS INC | 5.44% | 42,912,904 | HELD |
| KYMR | KYMERA THERAPEUTICS INC | 4.97% | 8,657,242 | HELD |
| INSM | INSMED Inc | 4.70% | 8,796,111 | ADDED (+18.5%) |
| CELC | Celcuity Inc. | 4.15% | 7,915,792 | HELD |
| KOD | Kodiak Sciences Inc. | 3.89% | 19,919,186 | HELD |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.12% | 5,604,483 | HELD |
| PRAX | Praxis Precision Medicines, Inc. | 2.94% | 1,753,198 | HELD |
| ALKS | Alkermes plc. | 2.63% | 10,012,267 | HELD |
| SMMT | SUMMIT THERAPEUTICS INC | 2.39% | 32,786,348 | TRIMMED (-9.9%) |
| GRAL | GRAIL, Inc. | 1.38% | 4,028,614 | HELD |
| ABCL | AbCellera Biologics Inc | 1.30% | 33,012,138 | ADDED (+9.0%) |
| IMVT | Immunovant, Inc. | 1.05% | 5,435,220 | TRIMMED (-0.4%) |
| IDYA | IDEAYA BIOSCIENCES INC | 0.94% | 5,010,030 | ADDED (+26.9%) |
| KNSA | Kiniksa Pharmaceuticals International, plc | 0.91% | 2,834,643 | ADDED (+0.3%) |
| ROIV | Roivant Sciences Ltd. | 0.84% | 4,716,831 | TRIMMED (-3.1%) |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 0.81% | 1,992,783 | HELD |
| IONS | IONIS PHARMACEUTICALS INC | 0.81% | 2,047,727 | HELD |
| EWTX | Edgewise Therapeutics, Inc. | 0.75% | 3,701,719 | TRIMMED (-43.7%) |
| REPL | REPLIMUNE GROUP INC | 0.61% | 11,045,336 | HELD |
| NRIX | NURIX THERAPEUTICS INC | 0.57% | 4,658,556 | HELD |
| STOK | STOKE THERAPEUTICS INC | 0.55% | 3,336,697 | HELD |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.53% | 4,345,736 | HELD |
| IMTX | Immatics N.V. | 0.48% | 9,508,565 | TRIMMED (-12.9%) |
| DNLI | Denali Therapeutics Inc. | 0.48% | 3,734,336 | ADDED (+0.1%) |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 0.42% | 852,164 | HELD |
| GPCR | STRUCTURE THERAPEUTICS INC | 0.39% | 1,432,529 | HELD |
| RAPP | RAPPORT THERAPEUTICS INC | 0.32% | 1,547,090 | HELD |
| ALMS | ALUMIS INC | 0.28% | 2,012,500 | HELD |
| PRLD | PRELUDE THERAPEUTICS INC | 0.27% | 10,123,824 | HELD |
| RLAY | Relay Therapeutics, Inc. | 0.27% | 2,826,783 | ADDED (+143.7%) |
| MIRM | Mirum Pharmaceuticals, Inc. | 0.26% | 445,975 | HELD |
| BCYC | BICYCLE THERAPEUTICS PLC-ADR | 0.23% | 10,885,357 | HELD |
| ELVN | ENLIVEN THERAPEUTICS INC | 0.23% | 905,191 | HELD |
| CLDX | Celldex Therapeutics, Inc. | 0.22% | 1,182,611 | ADDED (+77.7%) |
| VRDN | Viridian Therapeutics, Inc.\DE | 0.22% | 2,383,025 | ADDED (+20.9%) |
| DSGN | DESIGN THERAPEUTICS INC | 0.19% | 2,678,430 | ADDED (+3.6%) |
| TRDA | ENTRADA THERAPEUTICS INC | 0.19% | 5,072,730 | HELD |
| FTH | FAETH THERAPEUTICS INC | 0.16% | 1,286,411 | NEW |
| AKTS | Aktis Oncology, Inc. | 0.16% | 996,351 | HELD |
| NGNE | NEUROGENE INC | 0.16% | 991,691 | HELD |
| JBIO | JADE BIOSCIENCES INC | 0.14% | 1,230,426 | TRIMMED (-25.0%) |
| TSHA | Taysha Gene Therapies, Inc. | 0.14% | 4,004,756 | HELD |
| RCUS | ARCUS BIOSCIENCES INC | 0.13% | 844,816 | ADDED (+103.3%) |
| IRON | DISC MEDICINE INC | 0.13% | 349,657 | HELD |
| ABSI | ABSCI CORP | 0.12% | 2,134,803 | HELD |
| GENB | GENERATE BIOMEDICINES INC | 0.12% | 1,423,602 | HELD |
| DBVT | DBV TECHNOLOGIES SA-SPON ADR | 0.12% | 1,461,425 | HELD |
| XENE | XENON PHARMACEUTICALS INC | 0.11% | 370,208 | HELD |
| TECX | TECTONIC THERAPEUTIC INC | 0.10% | 607,788 | HELD |
| CERS | CERUS CORP | 0.09% | 6,395,431 | TRIMMED (-36.1%) |
| CTMX | CYTOMX THERAPEUTICS INC | 0.09% | 4,975,826 | HELD |
| DYN | DYNE THERAPEUTICS INC | 0.09% | 813,449 | HELD |
| CYTK | CYTOKINETICS INC | 0.09% | 211,267 | NEW |
| XNCR | XENCOR INC | 0.09% | 1,102,106 | HELD |
| SION | Sionna Therapeutics, Inc. | 0.09% | 400,000 | HELD |
| NTLA | Intellia Therapeutics, Inc. | 0.08% | 930,232 | NEW |
| PBLS | PARABILIS MEDICINES INC | 0.07% | 500,000 | NEW |
| MPLT | MAPLIGHT THERAPEUTICS INC | 0.07% | 364,705 | HELD |
| AVLN | AVALYN PHARMA INC | 0.06% | 350,000 | NEW |
| EVMN | EVOMMUNE INC | 0.06% | 847,390 | HELD |
| BNTX | BioNTech SE | 0.06% | 119,743 | HELD |
| TNGX | TANGO THERAPEUTICS INC | 0.05% | 333,333 | NEW |
| AVTX | AVALO THERAPEUTICS INC | 0.05% | 550,000 | NEW |
| SERA | SERA PROGNOSTICS INC-A | 0.05% | 5,498,170 | HELD |
| VSTM | Verastem, Inc. | 0.05% | 2,499,338 | ADDED (+327.4%) |
| SGMT | SAGIMET BIOSCIENCES INC-A | 0.04% | 952,996 | HELD |
| EIKN | Eikon Therapeutics, Inc. | 0.04% | 555,555 | HELD |
| LBRX | LB PHARMACEUTICALS INC | 0.03% | 200,000 | HELD |
| VTVT | VTV THERAPEUTICS INC- CL A | 0.03% | 148,314 | HELD |
| WVE | Wave Life Sciences, Inc. | 0.02% | 822,638 | HELD |
| TARA | PROTARA THERAPEUTIC INC | 0.02% | 971,614 | HELD |
| TCRX | TSCAN THERAPEUTICS INC | 0.01% | 2,784,792 | HELD |
| IMNM | IMMUNOME INC | 0.01% | 55,306 | NEW |
| SKYE | Skye Bioscience, Inc. | 0.01% | 1,575,243 | HELD |
| SANA | SANA BIOTECHNOLOGY INC | 0.01% | 310,483 | HELD |
| ALGS | ALIGOS THERAPEUTICS INC | <0.01% | 83,055 | HELD |
| TYRA | TYRA BIOSCIENCES INC | <0.01% | 10,607 | HELD |
The weights above sum to 99.2% of the fund’s reported 13F value. Only positions matched to a U.S.-listed ticker are listed; the remainder sits in unmatched or non-equity positions in the filing.
Exited this quarter: ABVX, ARGX, CMPS, CTNM, IMCR, PHVS, SYRE.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 14, 2026. CIK 0001263508. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only.
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.